Russell Investments Group Ltd. trimmed its holdings in shares of MAXIMUS, Inc. (NYSE:MMS) by 9.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 249,375 shares of the health services provider’s stock after selling 24,644 shares during the period. Russell Investments Group Ltd. owned about 0.39% of MAXIMUS worth $19,267,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of the company. Victory Capital Management Inc. boosted its holdings in shares of MAXIMUS by 2.6% during the second quarter. Victory Capital Management Inc. now owns 4,014,441 shares of the health services provider’s stock worth $291,207,000 after purchasing an additional 102,416 shares during the period. APG Asset Management N.V. boosted its holdings in shares of MAXIMUS by 54.7% during the second quarter. APG Asset Management N.V. now owns 1,227,400 shares of the health services provider’s stock worth $78,184,000 after purchasing an additional 433,800 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of MAXIMUS by 18.8% during the second quarter. Skandinaviska Enskilda Banken AB publ now owns 1,137,027 shares of the health services provider’s stock worth $82,480,000 after purchasing an additional 179,581 shares during the period. P2 Capital Partners LLC boosted its holdings in shares of MAXIMUS by 1.0% during the second quarter. P2 Capital Partners LLC now owns 1,083,594 shares of the health services provider’s stock worth $78,604,000 after purchasing an additional 11,000 shares during the period. Finally, Mondrian Investment Partners LTD boosted its holdings in shares of MAXIMUS by 12.9% during the second quarter. Mondrian Investment Partners LTD now owns 985,851 shares of the health services provider’s stock worth $71,514,000 after purchasing an additional 112,386 shares during the period. Institutional investors own 94.52% of the company’s stock.
In related news, General Counsel David Francis sold 6,496 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $77.43, for a total value of $502,985.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Russell A. Beliveau sold 1,000 shares of the stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $77.46, for a total transaction of $77,460.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 55,496 shares of company stock valued at $4,398,575. 2.20% of the stock is owned by insiders.
A number of analysts have recently weighed in on MMS shares. Canaccord Genuity increased their target price on shares of MAXIMUS from $72.00 to $77.00 and gave the stock a “hold” rating in a report on Tuesday, August 13th. Wells Fargo & Co reiterated a “market perform” rating and set a $83.00 target price on shares of MAXIMUS in a report on Friday, August 9th. Finally, ValuEngine upgraded shares of MAXIMUS from a “sell” rating to a “hold” rating in a report on Friday, October 25th.
Shares of MAXIMUS stock traded up $0.40 during trading on Friday, reaching $76.39. 231,149 shares of the stock were exchanged, compared to its average volume of 315,448. The stock’s fifty day moving average is $76.04 and its 200 day moving average is $74.85. The firm has a market cap of $4.84 billion, a price-to-earnings ratio of 22.47, a price-to-earnings-growth ratio of 1.85 and a beta of 0.82. MAXIMUS, Inc. has a 1 year low of $60.00 and a 1 year high of $82.02.
MAXIMUS (NYSE:MMS) last posted its earnings results on Thursday, August 8th. The health services provider reported $0.97 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.93 by $0.04. MAXIMUS had a net margin of 8.44% and a return on equity of 20.72%. The company had revenue of $730.70 million during the quarter, compared to analyst estimates of $754.81 million. During the same period in the prior year, the business posted $0.91 earnings per share. MAXIMUS’s revenue for the quarter was up 22.2% on a year-over-year basis. On average, analysts predict that MAXIMUS, Inc. will post 3.73 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Investors of record on Friday, November 15th will be paid a $0.28 dividend. This is an increase from MAXIMUS’s previous quarterly dividend of $0.25. This represents a $1.12 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date is Thursday, November 14th. MAXIMUS’s dividend payout ratio is presently 29.41%.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Read More: Why is the conference call important?
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.